Increased uric acid to high-density lipoprotein ratio positively correlated with stroke risk

Tieshi Zhu1, Yong He2, Erxinxian Bei1,3

  • 1Department of Neurology, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, China.

PubMed

Insights

The Uric Acid-to-HDL Ratio (UHR) is linked to a higher stroke risk. This study found a significant positive correlation between UHR and stroke, emphasizing its potential as a predictive marker.

Area of Science:

  • Cardiovascular Health
  • Metabolic Syndrome
  • Neurology

Background:

  • The Uric Acid-to-HDL Ratio (UHR) is a novel index associated with hypertension and diabetes.
  • Previous research linked UHR to ischemic heart disease and coronary artery function.
  • Limited studies have explored the association between UHR and stroke risk.

Purpose of the Study:

  • To investigate the relationship between UHR and the risk of stroke.
  • To assess the nonlinear association between UHR and stroke incidence.
  • To determine if UHR can serve as a predictive marker for stroke.

Main Methods:

  • Analysis of data from 33,192 individuals in the NHANES 1999-2023 database.
  • Utilized restricted cubic spline (RCS) analysis to evaluate nonlinear relationships.
  • Employed logistic regression to assess UHR as a continuous variable and by quartiles.

Main Results:

  • UHR showed a significant positive association with stroke risk (OR=1.02, 95% CI 1.01-1.03).
  • Individuals in the highest quartile of UHR had a 31% increased risk of stroke (OR=1.31, 95% CI 1.11-1.55).
  • The association was linear, not nonlinear (p for nonlinearity=0.65).

Conclusions:

  • A significant positive correlation exists between UHR and stroke risk.
  • Elevated UHR levels are associated with an increased likelihood of experiencing a stroke.
  • UHR may be a valuable biomarker for stroke risk assessment.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
301
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
97
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
40
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
890